Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20211
20221
20235
20242
20257

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
United Therapeutics2
AbbVie1
Alnylam Pharmaceuticals1
Astria Therapeutics, Inc.1
Avidity Biosciences, Inc.1
Celldex Therapeutics1
Erasmus Medical Center1
Janneke van de Wijgert1
Longboard Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy2
Seizures2
Amyloidosis1
Angioedema1
Angioedemas, Hereditary1
Asthma1
Cardiomyopathies1
Cardiovascular Diseases1
Chronic Urticaria1
Connective Tissue Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.